The tumour antigen PRAME is a subunit of a Cul2 ubiquitin ligase and associates with active NFY promoters

[1]  Simon J. van Heeringen,et al.  GimmeMotifs: a de novo motif prediction pipeline for ChIP-sequencing experiments , 2010, Bioinform..

[2]  Giuseppe Testa,et al.  Jmjd3 contributes to the control of gene expression in LPS-activated macrophages , 2009, The EMBO journal.

[3]  Nathaniel D. Heintzman,et al.  Histone modifications at human enhancers reflect global cell-type-specific gene expression , 2009, Nature.

[4]  Giulia Piaggio,et al.  Posttranslational regulation of NF-YA modulates NF-Y transcriptional activity. , 2008, Molecular biology of the cell.

[5]  K. Partheen,et al.  Four potential biomarkers as prognostic factors in stage III serous ovarian adenocarcinomas , 2008, International journal of cancer.

[6]  H. Stunnenberg,et al.  Genome-wide profiling of PPARgamma:RXR and RNA polymerase II occupancy reveals temporal activation of distinct metabolic pathways and changes in RXR dimer composition during adipogenesis. , 2008, Genes & development.

[7]  Martijn A. Huynen,et al.  Proteomic Profiling of Plasmodium Sporozoite Maturation Identifies New Proteins Essential for Parasite Development and Infectivity , 2008, PLoS pathogens.

[8]  J. Astola,et al.  Systematic bioinformatic analysis of expression levels of 17,330 human genes across 9,783 samples from 175 types of healthy and pathological tissues , 2008, Genome Biology.

[9]  Clifford A. Meyer,et al.  Model-based Analysis of ChIP-Seq (MACS) , 2008, Genome Biology.

[10]  S. Paydaş.  Is everything known in all faces of iceberg in PRAME? , 2008, Leukemia research.

[11]  A. Hart,et al.  PRAME expression and clinical outcome of breast cancer , 2008, British Journal of Cancer.

[12]  L. O’Driscoll,et al.  Prevalence and prognostic and predictive relevance of PRAME in breast cancer , 2008, Breast Cancer Research and Treatment.

[13]  Giulia Piaggio,et al.  NF-Y Dependent Epigenetic Modifications Discriminate between Proliferating and Postmitotic Tissue , 2008, PloS one.

[14]  William B. Redwine,et al.  Characterization of Cullin-box Sequences That Direct Recruitment of Cul2-Rbx1 and Cul5-Rbx2 Modules to Elongin BC-based Ubiquitin Ligases* , 2008, Journal of Biological Chemistry.

[15]  D. Merico,et al.  The Histone-Like NF-Y Is a Bifunctional Transcription Factor , 2008, Molecular and Cellular Biology.

[16]  F. Prósper,et al.  Epigenetic regulation of PRAME gene in chronic myeloid leukemia. , 2007, Leukemia research.

[17]  H. Saluz,et al.  Hypomethylation of PRAME is responsible for its aberrant overexpression in human malignancies , 2007, Genes, chromosomes & cancer.

[18]  Christina Chaivorapol,et al.  Systematic Identification of cis-Regulatory Sequences Active in Mouse and Human Embryonic Stem Cells , 2007, PLoS genetics.

[19]  D. Steinbach,et al.  PRAME expression is not associated with down-regulation of retinoic acid signaling in primary acute myeloid leukemia. , 2007, Cancer genetics and cytogenetics.

[20]  Dustin E. Schones,et al.  High-Resolution Profiling of Histone Methylations in the Human Genome , 2007, Cell.

[21]  David N. Messina,et al.  Evolutionary and Biomedical Insights from the Rhesus Macaque Genome , 2007, Science.

[22]  Nathaniel D. Heintzman,et al.  Distinct and predictive chromatin signatures of transcriptional promoters and enhancers in the human genome , 2007, Nature Genetics.

[23]  H. Stunnenberg,et al.  Identification of novel functional TBP‐binding sites and general factor repertoires , 2007, The EMBO journal.

[24]  M. Washburn,et al.  Quantitative proteomic analysis of distinct mammalian Mediator complexes using normalized spectral abundance factors , 2006, Proceedings of the National Academy of Sciences.

[25]  Michael K. Coleman,et al.  Analyzing chromatin remodeling complexes using shotgun proteomics and normalized spectral abundance factors. , 2006, Methods.

[26]  W. Tansey,et al.  The proteasome: a utility tool for transcription? , 2006, Current opinion in genetics & development.

[27]  Hongyue Dai,et al.  Gene expression changes associated with progression and response in chronic myeloid leukemia. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[28]  Hendrik G. Stunnenberg,et al.  MBD2/NuRD and MBD3/NuRD, Two Distinct Complexes with Different Biochemical and Functional Properties , 2006, Molecular and Cellular Biology.

[29]  R. Bernards,et al.  The Human Tumor Antigen PRAME Is a Dominant Repressor of Retinoic Acid Receptor Signaling , 2005, Cell.

[30]  C. Ponting,et al.  Duplication and positive selection among hominin-specific PRAME genes , 2005, BMC Genomics.

[31]  M. Mann,et al.  Exponentially Modified Protein Abundance Index (emPAI) for Estimation of Absolute Protein Amount in Proteomics by the Number of Sequenced Peptides per Protein*S , 2005, Molecular & Cellular Proteomics.

[32]  Jiang Zhu,et al.  NF-Ya activates multiple hematopoietic stem cell (HSC) regulatory genes and promotes HSC self-renewal. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[33]  B. Tombal,et al.  Tumor-associated antigen preferentially expressed antigen of melanoma (PRAME) induces caspase-independent cell death in vitro and reduces tumorigenicity in vivo. , 2005, Cancer research.

[34]  B. Ljung,et al.  The gene expression signatures of melanoma progression , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[35]  K. Shokat,et al.  The F Box Protein Dsg1/Mdm30 Is a Transcriptional Coactivator that Stimulates Gal4 Turnover and Cotranscriptional mRNA Processing , 2005, Cell.

[36]  Keiichi I Nakayama,et al.  VHL-box and SOCS-box domains determine binding specificity for Cul2-Rbx1 and Cul5-Rbx2 modules of ubiquitin ligases. , 2004, Genes & development.

[37]  F. Berthold,et al.  The Tumor-Associated Antigen PRAME Is Universally Expressed in High-Stage Neuroblastoma and Associated with Poor Outcome , 2004, Clinical Cancer Research.

[38]  M. Mann,et al.  Trypsin Cleaves Exclusively C-terminal to Arginine and Lysine Residues*S , 2004, Molecular & Cellular Proteomics.

[39]  P. Mermillod,et al.  Identification of a new expanding family of genes characterized by atypical LRR domains. Localization of a cluster preferentially expressed in oocyte , 2003, FEBS letters.

[40]  J. Deng,et al.  The B subunit of the CCAAT box binding transcription factor complex (CBF/NF-Y) is essential for early mouse development and cell proliferation. , 2003, Cancer research.

[41]  Chiara Vecchi,et al.  Dynamic Recruitment of NF-Y and Histone Acetyltransferases on Cell-cycle Promoters* , 2003, Journal of Biological Chemistry.

[42]  F. Guadagni,et al.  Requirement for down-regulation of the CCAAT-binding activity of the NF-Y transcription factor during skeletal muscle differentiation. , 2003, Molecular biology of the cell.

[43]  G. Cagney,et al.  Methylation of Histone H3 by Set2 in Saccharomyces cerevisiae Is Linked to Transcriptional Elongation by RNA Polymerase II , 2003, Molecular and Cellular Biology.

[44]  D. Page,et al.  Incomplete reactivation of Oct4-related genes in mouse embryos cloned from somatic nuclei , 2003, Development.

[45]  R. Mantovani,et al.  Interactions between p300 and Multiple NF-Y Trimers Govern Cyclin B2 Promoter Function* , 2003, The Journal of Biological Chemistry.

[46]  R. Conaway,et al.  Emerging Roles of Ubiquitin in Transcription Regulation , 2002, Science.

[47]  D. Steinbach,et al.  Clinical implications of PRAME gene expression in childhood acute myeloid leukemia. , 2002, Cancer genetics and cytogenetics.

[48]  I. Weissman,et al.  Stem cells, cancer, and cancer stem cells , 2001, Nature.

[49]  Nevan J. Krogan,et al.  COMPASS: A complex of proteins associated with a trithorax-related SET domain protein , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[50]  A. Caudy,et al.  Regulation of Transcriptional Activation Domain Function by Ubiquitin , 2001, Science.

[51]  Fang Yang,et al.  An abundance of X-linked genes expressed in spermatogonia , 2001, Nature Genetics.

[52]  J. Yates,et al.  Large-scale analysis of the yeast proteome by multidimensional protein identification technology , 2001, Nature Biotechnology.

[53]  S. Elledge,et al.  Rbx1, a component of the VHL tumor suppressor complex and SCF ubiquitin ligase. , 1999, Science.

[54]  W. Kaelin,et al.  The Elongin BC complex interacts with the conserved SOCS-box motif present in members of the SOCS, ras, WD-40 repeat, and ankyrin repeat families. , 1998, Genes & development.

[55]  A. Wolffe,et al.  Xenopus NF‐Y pre‐sets chromatin to potentiate p300 and acetylation‐responsive transcription from the Xenopus hsp70 promoter in vivo , 1998, The EMBO journal.

[56]  Millard,et al.  PRAME, a gene encoding an antigen recognized on a human melanoma by cytolytic T cells, is expressed in acute leukaemia cells , 1998, British journal of haematology.

[57]  B. Crombrugghe,et al.  Role of the CCAAT-binding protein CBF/NF-Y in transcription. , 1998, Trends in biochemical sciences.

[58]  W. Kaelin,et al.  Regulation of Hypoxia-Inducible mRNAs by the von Hippel-Lindau Tumor Suppressor Protein Requires Binding to Complexes Containing Elongins B/C and Cul2 , 1998, Molecular and Cellular Biology.

[59]  R. Currie.  NF-Y Is Associated with the Histone Acetyltransferases GCN5 and P/CAF* , 1998, The Journal of Biological Chemistry.

[60]  P. Coulie,et al.  Characterization of an antigen that is recognized on a melanoma showing partial HLA loss by CTL expressing an NK inhibitory receptor. , 1997, Immunity.

[61]  S. Maity,et al.  Recombinant rat CBF-C, the third subunit of CBF/NFY, allows formation of a protein-DNA complex with CBF-A and CBF-B and with yeast HAP2 and HAP3. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[62]  Kentaro Takahashi,et al.  Von Hippel-Lindau Disease , 2024 .

[63]  Michael P Washburn,et al.  Proteomic analysis by multidimensional protein identification technology. , 2006, Methods in molecular biology.

[64]  Raymond J. Deshaies,et al.  Function and regulation of cullin–RING ubiquitin ligases , 2005, Nature Reviews Molecular Cell Biology.

[65]  T. Yokota,et al.  Bmc Developmental Biology Expression Profiling in Transgenic Fvb/n Embryonic Stem Cells Overexpressing Stat3 , 2022 .